Profile picture

Professor Bjorn Knollmann

Vanderbilt University Medical Center, Nashville (United States of America)
Membership: ESC Professional Member
Follow
Biography
Bjorn Knollmann received a MD from the University of Cincinnati and a PhD in Pharmacology from Georgetown University. He is board-certified in Internal Medicine and Clinical Pharmacology. Bjorn Knollmann currently is Professor of Medicine and Pharmacology at Vanderbilt University School of Medicine, Nashville, Tennessee, USA. He holds the William Stokes Chair of Experimental Therapeutics and directs the Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART). He is also editor of The Goodman & Gilman’s Pharmacological Basis of Therapeutics textbook of Pharmacology. His research is focused on studying molecular mechanism and new treatments for atrial and ventricular arrhythmia and sudden cardiac death.
Logo ESC

Contributor content

Cardiac myosin inhibitor MYK-581 prevents development of hypertrophic cardiomyopathy phenotype in human iPSC models
Presentation
Cardiac myosin inhibitor MYK-581 prevents development of hypertrophic cardiomyopathy phenotype in human iPSC models
Hormones and heart maturation.
Presentation
Hormones and heart maturation.

ESC 365 is supported by